Molecular Biology Enzymes, Reagents, and Kits Market Size, Share, and Trends 2025 to 2034

The global molecular biology enzymes, reagents, and kits market is projected to grow from USD 27.68 billion in 2025 to USD 63.58 billion by 2034, exhibiting a CAGR of 9.68%. Market expansion is fueled by rising genomic applications, increasing demand for molecular diagnostics, personalized medicine, R&D investment, and innovations in next-generation sequencing and laboratory automation.

Last Updated : August 2025  |  Report Code : 5327  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Molecular Biology Enzymes Reagents and Kits Market 

5.1. COVID-19 Landscape: Molecular Biology Enzymes Reagents and Kits Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Molecular Biology Enzymes Reagents and Kits Market, By Technique / Technology Type

8.1. Molecular Biology Enzymes Reagents and Kits Market Revenue and Volume Forecast, by Technique / Technology Type

8.1.1. Conventional PCR

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Real-Time / Quantitative PCR (qPCR)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Sanger Sequencing

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Next-Generation Sequencing (NGS)

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. LAMP (Loop-mediated Isothermal Amplification)

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Other Molecular Biology Techniques (e.g., CRISPR-based diagnostics, digital PCR)

8.1.6.1. Market Revenue and Volume Forecast

Chapter 9. Global Molecular Biology Enzymes Reagents and Kits Market, By Raw Material Type

9.1. Molecular Biology Enzymes Reagents and Kits Market Revenue and Volume Forecast, by Raw Material Type

9.1.1. Enzymes

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. dNTPs

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Buffers & Additives

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Primers & Probes

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Sequencing-Specific Reagents

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. LAMP-Specific Components

9.1.6.1. Market Revenue and Volume Forecast

9.1.7. Others

9.1.7.1. Market Revenue and Volume Forecast

Chapter 10. Global Molecular Biology Enzymes Reagents and Kits Market, By End-User

10.1. Molecular Biology Enzymes Reagents and Kits Market Revenue and Volume Forecast, by End-User

10.1.1. IVD Kit Manufacturers

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Conventional PCR

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Clinical Diagnostic Laboratories

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Biotech & Pharma Companies (including R&D divisions)

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Other Molecular Biology Techniques (e.g., CRISPR-based diagnostics, digital PCR)

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. CROs and CDMOs

10.1.6.1. Market Revenue and Volume Forecast

10.1.7. Public Health Laboratories

10.1.7.1. Market Revenue and Volume Forecast

10.1.8. Other Molecular Biology Techniques (e.g., CRISPR-based diagnostics, digital PCR)

10.1.8.1. Market Revenue and Volume Forecast

10.1.9. Veterinary Diagnostics Labs

10.1.9.1. Market Revenue and Volume Forecast

10.1.10. Other Molecular Biology Techniques (e.g., CRISPR-based diagnostics, digital PCR)

10.1.10.1. Market Revenue and Volume Forecast

10.1.11. Agriculture & Breeding Labs (Plant & Animal Genotyping)

10.1.11.1. Market Revenue and Volume Forecast

10.1.5. Other Molecular Biology Techniques (e.g., CRISPR-based diagnostics, digital PCR)

10.1.12.1. Market Revenue and Volume Forecast

10.1.12. Other Molecular Biology Techniques (e.g., CRISPR-based diagnostics, digital PCR)

Chapter 11. Global Molecular Biology Enzymes Reagents and Kits Market, By Application Type

11.1. Molecular Biology Enzymes Reagents and Kits Market Revenue and Volume Forecast, by Application Type

11.1.1. Clinical Diagnostics

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Research Applications

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Single-cell Analysis (scRNAseq prep workflows)

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Industrial & Biopharma R&D

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Vaccine Development (pathogen characterization, strain identification)

11.1.5.1. Market Revenue and Volume Forecast

11.1.5. Public Health and Epidemiological Surveillance

11.1.5.1. Market Revenue and Volume Forecast

11.1.5. Agricultural and Environmental Applications

11.1.5.1. Market Revenue and Volume Forecast

11.1.5. Forensic and Identity Testing

11.1.5.1. Market Revenue and Volume Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Molecular Biology Enzymes Reagents and Kits Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.1.2. Market Revenue and Volume Forecast, by Raw Material Type

12.1.3. Market Revenue and Volume Forecast, by End-User

12.1.4. Market Revenue and Volume Forecast, by Application Type

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.1.5.2. Market Revenue and Volume Forecast, by Raw Material Type

12.1.5.3. Market Revenue and Volume Forecast, by End-User

12.1.5.4. Market Revenue and Volume Forecast, by Application Type

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.1.6.2. Market Revenue and Volume Forecast, by Raw Material Type

12.1.6.3. Market Revenue and Volume Forecast, by End-User

12.1.6.4. Market Revenue and Volume Forecast, by Application Type

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.2.2. Market Revenue and Volume Forecast, by Raw Material Type

12.2.3. Market Revenue and Volume Forecast, by End-User

12.2.4. Market Revenue and Volume Forecast, by Application Type

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.2.5.2. Market Revenue and Volume Forecast, by Raw Material Type

12.2.5.3. Market Revenue and Volume Forecast, by End-User

12.2.5.4. Market Revenue and Volume Forecast, by Application Type

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.2.6.2. Market Revenue and Volume Forecast, by Raw Material Type

12.2.6.3. Market Revenue and Volume Forecast, by End-User

12.2.6.4. Market Revenue and Volume Forecast, by Application Type

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.2.7.2. Market Revenue and Volume Forecast, by Raw Material Type

12.2.7.3. Market Revenue and Volume Forecast, by End-User

12.2.7.4. Market Revenue and Volume Forecast, by Application Type

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.2.8.2. Market Revenue and Volume Forecast, by Raw Material Type

12.2.8.3. Market Revenue and Volume Forecast, by End-User

12.2.8.4. Market Revenue and Volume Forecast, by Application Type

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.3.2. Market Revenue and Volume Forecast, by Raw Material Type

12.3.3. Market Revenue and Volume Forecast, by End-User

12.3.4. Market Revenue and Volume Forecast, by Application Type

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.3.5.2. Market Revenue and Volume Forecast, by Raw Material Type

12.3.5.3. Market Revenue and Volume Forecast, by End-User

12.3.5.4. Market Revenue and Volume Forecast, by Application Type

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.3.6.2. Market Revenue and Volume Forecast, by Raw Material Type

12.3.6.3. Market Revenue and Volume Forecast, by End-User

12.3.6.4. Market Revenue and Volume Forecast, by Application Type

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.3.7.2. Market Revenue and Volume Forecast, by Raw Material Type

12.3.7.3. Market Revenue and Volume Forecast, by End-User

12.3.7.4. Market Revenue and Volume Forecast, by Application Type

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.3.8.2. Market Revenue and Volume Forecast, by Raw Material Type

12.3.8.3. Market Revenue and Volume Forecast, by End-User

12.3.8.4. Market Revenue and Volume Forecast, by Application Type

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.4.2. Market Revenue and Volume Forecast, by Raw Material Type

12.4.3. Market Revenue and Volume Forecast, by End-User

12.4.4. Market Revenue and Volume Forecast, by Application Type

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.4.5.2. Market Revenue and Volume Forecast, by Raw Material Type

12.4.5.3. Market Revenue and Volume Forecast, by End-User

12.4.5.4. Market Revenue and Volume Forecast, by Application Type

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.4.6.2. Market Revenue and Volume Forecast, by Raw Material Type

12.4.6.3. Market Revenue and Volume Forecast, by End-User

12.4.6.4. Market Revenue and Volume Forecast, by Application Type

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.4.7.2. Market Revenue and Volume Forecast, by Raw Material Type

12.4.7.3. Market Revenue and Volume Forecast, by End-User

12.4.7.4. Market Revenue and Volume Forecast, by Application Type

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.4.8.2. Market Revenue and Volume Forecast, by Raw Material Type

12.4.8.3. Market Revenue and Volume Forecast, by End-User

12.4.8.4. Market Revenue and Volume Forecast, by Application Type

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.5.2. Market Revenue and Volume Forecast, by Raw Material Type

12.5.3. Market Revenue and Volume Forecast, by End-User

12.5.4. Market Revenue and Volume Forecast, by Application Type

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.5.5.2. Market Revenue and Volume Forecast, by Raw Material Type

12.5.5.3. Market Revenue and Volume Forecast, by End-User

12.5.5.4. Market Revenue and Volume Forecast, by Application Type

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Technique / Technology Type

12.5.6.2. Market Revenue and Volume Forecast, by Raw Material Type

12.5.6.3. Market Revenue and Volume Forecast, by End-User

12.5.6.4. Market Revenue and Volume Forecast, by Application Type

Chapter 13. Company Profiles

13.1. Thermo Fisher Scientific, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerTechnique / Technology Typeance

13.1.4. Recent Initiatives

13.2. Illumina, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerTechnique / Technology Typeance

13.2.4. Recent Initiatives

13.3. Agilent Technologies, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerTechnique / Technology Typeance

13.3.4. Recent Initiatives

13.4. QIAGEN

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerTechnique / Technology Typeance

13.4.4. Recent Initiatives

13.5. Promega Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerTechnique / Technology Typeance

13.5.4. Recent Initiatives

13.6. New England Biolabs

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerTechnique / Technology Typeance

13.6.4. Recent Initiatives

13.7. Merck KGaA

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerTechnique / Technology Typeance

13.7.4. Recent Initiatives

13.8. F. Hoffmann-La Roche Ltd.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerTechnique / Technology Typeance

13.8.4. Recent Initiatives

13.9. Bio-Rad Laboratories, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerTechnique / Technology Typeance

13.9.4. Recent Initiatives

13.10. Takara Bio, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerTechnique / Technology Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global molecular biology enzymes, reagents, and kits market size is expected to grow from USD 25.24 billion in 2024 to USD 63.58 billion by 2034.

The molecular biology enzymes, reagents, and kits market is anticipated to grow at a CAGR of 9.68% between 2025 and 2034.

The major players operating in the molecular biology enzymes, reagents, and kits market are Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, Promega Corporation, New England Biolabs, Merck KGaA, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Takara Bio, Inc., LGC Limited, Bausch Health Companies Inc., and Others.

The driving factors of the molecular biology enzymes, reagents, and kits market are the increase in the use of molecular diagnostics also increased incidence of genetic diseases.

North America region will lead the global molecular biology enzymes, reagents, and kits market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client